Melewar Industrial Group Berhad (KLSE:MELEWAR)

Longboard Pharmaceuticals Balance Sheet

Financials in millions MYR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	15.8	70.58	81.05	114.75	10.84	7.87
Short-Term Investments	36.35	-	-	-	90.09	36.4
Trading Asset Securities	3.35	6.4	5	2.6	-	-
Cash & Short-Term Investments	55.5	76.97	86.06	117.35	100.93	44.27
Cash Growth	11.29%	-10.55%	-26.67%	16.27%	128.00%	-17.55%
Accounts Receivable	74.57	105.96	67.66	71.1	38.95	73.87
Other Receivables	8.6	3.99	2.57	2.44	1.09	3.79
Receivables	83.17	109.95	70.22	73.54	40.04	77.66
Inventory	190.59	268.54	178.37	286.8	228.2	157.12
Prepaid Expenses	-	1.15	1.45	0.81	1.02	0.6
Other Current Assets	0.21	0.9	2.63	6.39	4.75	3.4
Total Current Assets	329.47	457.51	338.73	484.88	374.94	283.04
Property, Plant & Equipment	398	405.03	412.33	403.46	404.21	396.27
Long-Term Deferred Tax Assets	1.13	0.3	0.59	0.64	0.84	1.01
Other Long-Term Assets	0.92	-	-	-	-	12.16
Total Assets	729.51	862.83	751.65	888.98	779.98	692.48
Accounts Payable	0.84	88.22	27.96	154.58	107.7	130.22
Accrued Expenses	-	10.23	4.55	8.47	7.89	4.72
Short-Term Debt	96.21	119.32	78.01	71.94	51.09	35.64
Current Portion of Long-Term Debt	-	6.72	12.37	7.88	7.81	7.57
Current Portion of Leases	0.56	0.78	0.78	0.64	1.28	2.76
Current Income Taxes Payable	0.89	1.28	0.62	2.8	2.7	0.2
Current Unearned Revenue	0.48	0.34	6.42	7.84	23.38	1.85
Other Current Liabilities	17.14	11.47	10.88	12.03	6.16	10.67
Total Current Liabilities	116.12	238.36	141.59	266.17	208.01	193.63
Long-Term Debt	0.44	7.84	10.09	22.41	27.24	27.24
Long-Term Leases	2.8	2.74	2.94	2.02	1.22	2.38
Long-Term Unearned Revenue	7.84	8.1	5.73	5.88	6.04	-
Long-Term Deferred Tax Liabilities	59.19	58.6	56.56	56.97	52.81	45.51
Other Long-Term Liabilities	-	-	-	-	-	0.21
Total Liabilities	186.38	315.64	216.92	353.46	295.33	268.96
Common Stock	253.79	253.79	250.21	250.21	250.21	250.21
Retained Earnings	65.6	70.04	65.72	79.35	44.32	2.32
Comprehensive Income & Other	92.98	92.52	93.68	80.46	76.27	72.95
Total Common Equity	412.37	416.35	409.61	410.02	370.8	325.48
Minority Interest	130.76	130.84	125.12	125.5	113.85	98.03
Shareholders' Equity	543.13	547.19	534.73	535.52	484.66	423.52
Total Liabilities & Equity	729.51	862.83	751.65	888.98	779.98	692.48
Total Debt	100.01	137.4	104.2	104.88	88.64	75.59
Net Cash (Debt)	-44.51	-60.43	-18.14	12.47	12.29	-31.32
Net Cash Growth	-	-	-	1.45%	-	-
Net Cash Per Share	-0.12	-0.17	-0.05	0.03	0.03	-0.09
Filing Date Shares Outstanding	359.46	359.46	359.46	359.42	359.42	359.42
Total Common Shares Outstanding	359.46	359.46	359.42	359.42	359.42	359.42
Working Capital	213.35	219.14	197.13	218.71	166.92	89.42
Book Value Per Share	1.15	1.16	1.14	1.14	1.03	0.91
Tangible Book Value	412.37	416.35	409.61	410.02	370.8	325.48
Tangible Book Value Per Share	1.15	1.16	1.14	1.14	1.03	0.91
Land	-	77	77	69	65	60
Buildings	-	58.81	57.11	59.61	66.11	66.91
Machinery	-	182.03	190.24	195.55	177.27	186.27
Construction In Progress	-	0.81	0.73	0.72	20.47	11.87

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.